Market Overview

Benzinga's Top Upgrades, Downgrades For February 21, 2017

Share:
Related MTOR
Watch These 8 Huge Put Purchases In Thursday Trade
Benzinga's Option Alert Recap From October 4
Related CYH
8 Stocks Moving On Trump's Latest Obamacare Comments
Mid-Afternoon Market Update: Badger Meter Falls On Downbeat Q3 Results; Diffusion Pharmaceuticals Shares Climb
Community Health Systems To Broadcast Third Quarter —…–7 Conference Call Live On The Internet (GuruFocus)

Top Upgrades

  • Analysts at KeyBanc upgraded Meritor Inc (NYSE: MTOR) from Sector Weight to Overweight. Meritor shares fell 0.63 percent to close at $15.73 on Friday.
  • Analysts at Mizuho upgraded Community Health Systems (NYSE: CYH) from Underperform to Neutral. Community Health shares rose 22.46 percent to $8.45 in pre-market trading.
  • Analysts at JP Morgan upgraded GasLog Ltd (NYSE: GLOG) from Underweight to Neutral. GasLog shares rose 0.94 percent to $16.10 in pre-market trading.
  • Deutsche Bank upgraded Star Bulk Carriers Corp. (NASDAQ: SBLK) from Hold to Buy. Star Bulk Carriers shares rose 1.60 percent to close at $8.26 on Friday.
  • Analysts at Raymond James upgraded Viper Energy Partners LP (NASDAQ: VNOM) from Market Perform to Strong Buy. Viper Energy Partners shares rose 3.12 percent to $18.16 in pre-market trading.
  • Piper Jaffray upgraded Workday Inc (NYSE: WDAY) from Neutral to Overweight. Workday shares closed at $88.43 on Friday.


Top Downgrades

  • Barrington Research downgraded DENTSPLY SIRONA Inc (NASDAQ: XRAY) from Outperform to Market Perform. Dentsply Sirona shares rose 0.51 percent to $63.00 in pre-market trading.
  • JP Morgan downgraded Bloomin' Brands Inc (NASDAQ: BLMN) from Overweight to Neutral. Bloomin Brands shares rose 5.30 percent to close at $18.86 on Friday.
  • SunTrust Robinson Humphrey downgraded Marriott International Inc (NASDAQ: MAR) from Buy to Hold. Marriott shares dropped 0.09 percent to close at $89.36 on Friday.
  • Jefferies downgraded Lumos Networks Corp (NASDAQ: LMOS) from Buy to Hold. Lumos Networks shares climbed 16.55 percent to $17.75 in pre-market trading.
  • Deutsche Bank downgraded Freeport-McMoRan Inc (NYSE: FCX) from Hold to Sell. Freeport-McMoRan shares fell 3.76 percent to $14.35 in pre-market trading.
  • Jefferies downgraded Omega Healthcare Investors Inc (NYSE: OHI) from Buy to Hold. Omega Healthcare shares fell 0.76 percent to $31.47 in pre-market trading.
  • Analysts at Barrington Research downgraded Huron Consulting Group (NASDAQ: HURN) from Outperform to Market Perform. Huron Consulting shares fell 8.58 percent to close at $42.60 on Friday.


Top Initiations

  • Analysts at Wells Fargo initiated coverage on Jagged Peak Energy Inc (NYSE: JAG) with a Outperform rating. Jagged Peak Energy shares closed at $13.50 on Friday.
  • Analysts at Credit Suisse initiated coverage on AnaptysBio Inc (NASDAQ: ANAB) with an Outperform rating. The price target for AnaptysBio is set to $34. AnaptysBio shares closed at $23.89 on Friday.
  • Analysts at JP Morgan initiated coverage on LKQ Corporation (NASDAQ: LKQ) with an Overweight rating. The price target for LKQ is set to $41. LKQ shares closed at $31.94 on Friday.
  • Analysts at Deutsche Bank initiated coverage on Jeld-Wen Holding Inc (NYSE: JELD) with a Buy rating. The price target for Jeld-Wen is set to $36. Jeld-Wen shares closed at $29.48 on Friday.
  • Analysts at JP Morgan initiated coverage on Jagged Peak Energy Inc (NYSE: JAG) with an Overweight rating. The price target for Jagged Peak Energy is set to $23. Jagged Peak Energy shares closed at $13.50 on Friday.
  • Analysts at BMO Capital initiated coverage of Jagged Peak Energy Inc (NYSE: JAG) with a Market Perform rating. The price target for Jagged Peak Energy is set to $17. Jagged Peak Energy shares closed at $13.50 on Friday.
  • Analysts at Barclays initiated coverage of Jeld-Wen Holding Inc (NYSE: JELD) with an Overweight rating. Jagged Peak Energy shares closed at $13.50 on Friday.
  • Analysts at Wedbush initiated coverage on Miragen Therapeutics, Inc. (NASDAQ: MGEN) with an Outperform rating. The price target for Miragen Therapeutics is set to $19. Miragen Therapeutics shares closed at $11.80 on Friday.

Latest Ratings for MTOR

DateFirmActionFromTo
Oct 2017BarclaysMaintainsEqual-Weight
Oct 2017UBSMaintainsNeutral
Oct 2017Longbow ResearchDowngradesBuyNeutral

View More Analyst Ratings for MTOR
View the Latest Analyst Ratings

Posted-In: Downgrades Initiations top upgradesUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (BLMN + ANAB)

View Comments and Join the Discussion!
Loading...

Partner Center

Loading...